VERTEX PHARMACEUTICALS: RAISES FY26 COMBINED GAAP AND NON-GAAP R&D, AIPR&D, SG&A EXPENSE GUIDANCE TO REFLECT CRINETICS INTEGRATION

Reuters · 1d ago

Please log in to view news